产品说明书

APX-115 free base

Print
Chemical Structure| 1270084-92-8 同义名 : Ewha-18278 free base;Isuzinaxib free base;EWHA-18278;APX 115;Isuzinaxib
CAS号 : 1270084-92-8
货号 : A1216684
分子式 : C17H17N3O
纯度 : 99%+
分子量 : 279.336
MDL号 : N/A
存储条件:

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 250 mg/mL(894.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 APX-115 is a potent, orally active pan-Nox inhibitor with Ki values of 1.08 μM, 0.57 μM and 0.63 μM for Nox1, Nox2 and Nox4, respectively[1].At a concentration of 5 μM for 60 min, APX-115 almost completely inhibited the expression of pro-inflammatory and necrotic molecules in high glucose-induced mouse podocyte cell lines[2].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.58mL

0.72mL

0.36mL

17.90mL

3.58mL

1.79mL

35.80mL

7.16mL

3.58mL

参考文献

[1]Kwon G, et al. A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: possible role of peroxisomal and mitochondrial biogenesis. Oncotarget. 2017 Jun 16;8(43):74217-74232.

[2]Cha JJ, et al. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. Lab Invest. 2017 Apr;97(4):419-431.